This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Walenkamp, M. J. E. Articles by Wit, J. M. Search for Related Content PubMed PubMed Citation Articles by Walenkamp, M. J. E. Articles by Wit, J. M. Related Collections Pediatric Endocrinology

A Variable Degree of Intrauterine and Postnatal Growth Retardation in a Family with a Missense Mutation in the Insulin-Like Growth Factor I Receptor

Departments of Pediatrics (M.J.E.W., H.J.v.d.K., H.A.v.D., M.F.K., M.K., J.M.W.) and Endocrinology and Metabolic Disorders (A.M.P., H.A.v.D., J.A.R., M.K.) and Center for Human and Clinical Genetics (S.G.K., M.H.B.), Leiden University Medical Center, 2300 RC Leiden, The Netherlands

Address all correspondence and requests for reprints to: M. J. E. Walenkamp, Department of Pediatrics J6-S, Leiden University Medical Center, P.O. Box 9600, 2300 RC Leiden, The Netherlands. E-mail: m.j.e.walenkamp{at}lumc.nl.

Context: The type 1 IGF-I receptor (IGF1R) mediates the biological functions of IGF-I. Binding of IGF-I to the IGF1R results in autophosphorylation of the intracellular ß-subunit and activation of intracellular signaling.

Objective: The objective of this study was to evaluate the functional characteristics of a novel IGF1R mutation and describe the phenotypic features of two patients with this mutation.

Design: The study was performed in a university hospital.

Patients: We describe a 35-yr-old female with mild intrauterine growth failure, progressive postnatal growth retardation, severe failure to thrive, and microcephaly. Her daughter was born with severe intrauterine growth retardation and also showed postnatal failure to thrive and microcephaly.

Results: We found a heterozygous G3148A nucleotide substitution in the IGF1R gene, changing a negatively charged glutamic acid at position 1050 into a positively charged lysine residue (E1050K). E1050 is a conserved residue in the intracellular kinase domain. Dermal fibroblasts of the mother showed normal binding of iodinated IGF-I, but autophosphorylation and activation of downstream signaling cascades upon challenging with IGF-I was markedly reduced. Consequently, the maximal [³H]thymidine incorporation upon challenge with a dose range of IGF-I was reduced compared with a panel of control cells (3.65 ± 1.79-fold vs. 6.75 ± 4.7-fold stimulation; P < 0.01). These data suggest that the mutation results in the inactivation of one copy of the IGF1R gene.

Conclusions: These two patients support the key role for IGF-I in intrauterine and postnatal growth. The different phenotypes of these and earlier described patients may be associated with variability in IGF-I signaling. The degree of intrauterine growth retardation may be partially determined by the presence or absence of maternal IGF-I resistance.

This article has been cited by other articles:

				C. Ohlsson, S. Mohan, K. Sjogren, A. Tivesten, J. Isgaard, O. Isaksson, J.-O. Jansson, and J. Svensson The Role of Liver-Derived Insulin-Like Growth Factor-I Endocr. Rev., August 1, 2009; 30(5): 494 - 535. [Abstract] [Full Text] [PDF]

				P. Fang, I. D. Schwartz, B. D. Johnson, M. A. Derr, C. T. Roberts Jr., V. Hwa, and R. G. Rosenfeld Familial Short Stature Caused by Haploinsufficiency of the Insulin-Like Growth Factor I Receptor due to Nonsense-Mediated Messenger Ribonucleic Acid Decay J. Clin. Endocrinol. Metab., May 1, 2009; 94(5): 1740 - 1747. [Abstract] [Full Text] [PDF]

				H A van Duyvenvoorde, M J E Kempers, T. B Twickler, J van Doorn, W J Gerver, C Noordam, M Losekoot, M Karperien, J M Wit, and A R M M Hermus Homozygous and heterozygous expression of a novel mutation of the acid-labile subunit Eur. J. Endocrinol., August 1, 2008; 159(2): 113 - 120. [Abstract] [Full Text] [PDF]

				M. J. E. Walenkamp, S. M. P. F. de Muinck Keizer-Schrama, M. de Mos, M. E. Kalf, H. A. van Duyvenvoorde, A. M. Boot, S. G. Kant, S. J. White, M. Losekoot, J. T. Den Dunnen, et al. Successful Long-Term Growth Hormone Therapy in a Girl with Haploinsufficiency of the Insulin-Like Growth Factor-I Receptor due to a Terminal 15q26.2->qter Deletion Detected by Multiplex Ligation Probe Amplification J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2421 - 2425. [Abstract] [Full Text] [PDF]

				M J E Walenkamp and J M Wit Genetic disorders in the GH IGF-I axis in mouse and man Eur. J. Endocrinol., August 1, 2007; 157(suppl_1): S15 - S26. [Abstract] [Full Text] [PDF]

				K. Inagaki, A. Tiulpakov, P. Rubtsov, P. Sverdlova, V. Peterkova, S. Yakar, S. Terekhov, and D. LeRoith A Familial Insulin-Like Growth Factor-I Receptor Mutant Leads to Short Stature: Clinical and Biochemical Characterization J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1542 - 1548. [Abstract] [Full Text] [PDF]

				J. Hoogendam, H. Farih-Sips, L. C. Wynaendts, C. W. G. M. Lowik, J. M. Wit, and M. Karperien Novel Mutations in the Parathyroid Hormone (PTH)/PTH-Related Peptide Receptor Type 1 Causing Blomstrand Osteochondrodysplasia Types I and II J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1088 - 1095. [Abstract] [Full Text] [PDF]